Search

The National Treatment Centre-Highland

The National Treatment Centre-Highland opened its doors to patients in April 2023. At a cost of £48 million this represented a significant investment by the Scottish Government for the provision of modern eye care for the North of Scotland.

BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device

BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.

Coventry Community Eye Hospital recognised as ‘Outstanding’

Care and Quality Commission awards CHEC highest possible rating.

WE KNOW THAT YOU ARE MORE THAN MEETS THE EYE

Charity’s new campaign aims to dispel negative perceptions of people living with sight loss.

SPOKE launches Indicative Guidance for contact lens opticians and independent prescribers

The Sector Partnership for Optical Knowledge and Education (SPOKE) has published two new Indicative Guidance documents.

Hertfordshire and West Essex ICB accredits CHEC as a system provider of gastroenterology services

CHEC Stevenage, a community-based hospital, aims to increase patient choice and maintain short waiting times.

New study uncovers key mechanism behind a common genetic cause of age-related visual loss

A groundbreaking study has revealed important insights into the mechanisms behind Fuchs Endothelial Corneal Dystrophy (FECD), a common cause of age-related visual loss, providing hope for future therapeutic developments, and finding implications for other neurological diseases. FECD is a common,...

Lord Provost commends Sight Scotland Veterans for incredible support during visit to charity’s Linburn Centre

The Lord Provost of Edinburgh, Councillor Robert Aldridge, has praised Sight Scotland Veterans for the ‘incredible support’ it provides to veterans living with sight loss during a recent visit to the charity’s Linburn Centre in West Lothian. The Lord Provost,...

Thomas Pocklington Trust and Guide Dogs expands student support services to include younger age group

Sight loss charities, Guide Dogs and Thomas Pocklington Trust (TPT) are working together to deliver advice and guidance to blind and partially sighted students, their families and carers and any professionals that support them. The two charities have partnered to...

Green Charter inspires the Optical Community

Green Charter – the optical community’s clear pathway for a sustainable future – attracted great interest at 100% Optical, with businesses keen to learn more about specific guidance. Launched by Opticare Innovations, the commercial arm of the OSA, the five...

Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy

Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy, offering new ways for future therapies to target this common, age-related cause of visual loss. In a landmark study, researchers supported by NIHR Moorfields Biomedical Research Centre, have identified...

AI detects eye changes that lead to sight loss in young people

Use of Artificial Intelligence (AI) can accurately predict when young people with the sight- threatening eye condition kerataconus need treatment to stabilise the cornea and prevent loss of vision. Developed by researchers at Moorfields Eye Hospital and UCL Institute of...